Saunders Hsu
Pediatric Hematology-Oncology · Sacramento, CANPI 1194858936
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $718 and has fallen 89.0% since, to $79 in 2025.
Across 149 payments — averaging $21.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$536
- Amgen$518
- AstraZeneca$474
- Sobi, Inc$349
- Servier Pharmaceuticals LLC$224
- Y-mabs Therapeutics, Inc.$123
- plus $975 from 21 others
What the payments were for
- Food & beverage$3,06996%
- Education$1294%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 26 | $536 |
| Amgen | 22 | $518 |
| AstraZeneca(2 entities) | 23 | $474 |
| Sobi, Inc | 17 | $349 |
| Servier Pharmaceuticals LLC | 12 | $224 |
| Y-mabs Therapeutics, Inc. | 4 | $123 |
| Pfizer | 5 | $119 |
| Bio Products Laboratory USA, Inc. | 5 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $89 |
| Emmaus Medical, Inc. | 4 | $63 |
| BTG International Inc. | 3 | $60 |
| Shire North American Group Inc | 3 | $54 |
| Bayer | 2 | $49 |
| Genentech USA, Inc. | 2 | $49 |
| RARE Disease Therapeutics, Inc. | 2 | $48 |
| Astellas Pharma US Inc | 2 | $47 |
| Global Blood Therapeutics, Inc. | 2 | $47 |
| Apellis Pharmaceuticals, Inc. | 2 | $41 |
| USWM, LLC | 1 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $28 |
| Foundation Medicine, Inc. | 1 | $24 |
| Chiesi USA, Inc. | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Acrotech Biopharma Inc. | 1 | $20 |
| Octapharma USA, Inc. | 1 | $19 |
| Apo-pharma USA, Inc. | 1 | $17 |
| United Therapeutics Corporation | 1 | $14 |
How this compares
$3,198 in reported general payments places this provider in the 65th percentile of 307 pediatric hematology-oncology providers in California.
See all pediatric hematology-oncology providers in California →
Other pediatric hematology-oncology in Sacramento
- Arun PanigrahiSacramento$103K
- Anjali PawarSacramento$28K
- Jonathan DucoreSacramento$23K
- Philip PizzoPalo Alto$2.6M
- Vinod BalasaMadera$508K
- Akshat JainRedlands$447K
- Noah FedermanLos Angeles$399K
- Vanessa Salinas-LunaOrange$344K
- Daniel KraftStanford$294K
- Arash MahajerinOrange$249K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.